e-learning
resources
Vienna 2012
Monday, 03.09.2012
Aspects of clinical asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monocyte inflammatory responsiveness and potential therapeutic target for pigeon fancier‘s hypersensitivity pneumonitis (HP)
C. McSharry, M. Morrison, G. Short, K. Prentice, K. Ruddock, E. Rawlinson, R. Adamson, K. Anderson (Glasgow, Kilmarnock, United Kingdom)
Source:
Annual Congress 2012 - Aspects of clinical asthma
Session:
Aspects of clinical asthma
Session type:
Thematic Poster Session
Number:
2391
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. McSharry, M. Morrison, G. Short, K. Prentice, K. Ruddock, E. Rawlinson, R. Adamson, K. Anderson (Glasgow, Kilmarnock, United Kingdom). Monocyte inflammatory responsiveness and potential therapeutic target for pigeon fancier‘s hypersensitivity pneumonitis (HP). Eur Respir J 2012; 40: Suppl. 56, 2391
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis
Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Year: 2017
Primed monocyte phenotype and function shift associated with avian related hypersensitivity pneumonitis
Source: Annual Congress 2008 - The adaptive and innate immune system at work
Year: 2008
Characterizing T cell responses associated with hypersensitivity pneumonitis in pigeon fanciers
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
The role of neutrophils in the asthmatic late-phase response in humans. Evidence for a non-specific bronchoalveolar inflammatory response
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006
Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007
Impaired function of regulatory T-cells in hypersensitivity pneumonitis
Source: Eur Respir J 2011; 37: 632-639
Year: 2011
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007
Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Corticosteroid (CS) therapy does not influence immune reactivity in patients with non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
γδ T cells contribute to local and systemic B cell reactivity in allergic eosinophilic airway inflammation but without a major influence on the TH1/TH2 balance
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002
Comparison of the inflammatory response between two chronic models of allergic lung inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007
Late-breaking abstract: Serum and blood cell culture Th17 cytokines in pigeon fanciers‘ hypersensitivity pneumonitis (HP)
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Master switches of T-cell activation and differentiation
Source: Eur Respir J 2007; 29: 804-812
Year: 2007
Biological monitoring of cellular effects of omalizumab with basophil degranulation test (BAT) in severe asthma
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice
Source: Eur Respir J 2003; 21: 11-18
Year: 2003
Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept